Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지

Prions and Prion Diseases: Fundamentals and Mechanistic Details

  • Ryou, Chong-Suk (Sanders Brown Center on Aging, Department of Microbiology, Immunology and Molecular Genetics, College of Medicine, University of Kentucky)
  • Published : 2007.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

Prion diseases, often called transmissible spongiform encephalopathies (TSEs), are infectious diseases that accompany neurological dysfunctions in many mammalian hosts. Prion diseases include Creutzfeldt-Jakob disease (CJD) in humans, bovine spongiform encephalopathy (BSE, "mad cow disease") in cattle, scrapie in sheep, and chronic wasting disease (CWD) in deer and elks. The cause of these fatal diseases is a proteinaceous pathogen termed prion that lacks functional nucleic acids. As demonstrated in the BSE outbreak and its transmission to humans, the onset of disease is not limited to a certain species but can be transmissible from one host species to another. Such a striking nature of prions has generated huge concerns in public health and attracted serious attention in the scientific communities. To date, the potential transmission of prions to humans via foodborne infection and iatrogenic routes has not been alleviated. Rather, the possible transmission of human to human or cervids to human aggravates the terrifying situation across the globe. In this review, basic features about prion diseases including clinical and pathological characteristics, etiology, and transmission of diseases are described. Based on recently accumulated evidences, the molecular and biochemical aspects of prions, with an emphasis on the molecular interactions involved in prion conversion that is critical during prion replication and pathogenesis, are also addressed.

Keywords

References

  1. Aguzzi, A. and M. Heikenwalder. 2005. Prions, cytokines, and chemokines: A meeting in lymphoid organs. Immunity 22: 145-154
  2. Alper, T., W. A. Cramp, D. A. Haig, and M. C. Clarke. 1967. Does the agent of scrapie replicate without nucleic acid? Nature 214: 764-766 https://doi.org/10.1038/214764a0
  3. Barnewitz, K., M. Maringer, G. Mitteregger, A. Giese, U. Bertsch, and H. A. Kretzschmar. 2006. Unaltered prion protein cleavage in plasminogen-deficient mice. Neurareport 17: 527-530 https://doi.org/10.1097/01.wnr.0000209003.55728.ac
  4. Belay, E., R. Maddox, E. Williams, M. Miller, P. Gambetti, and L. Schonberger. 2004. Chronic wasting disease and potential transmission to humans. Emerg. Infect. Dis. 10: 977-984 https://doi.org/10.3201/eid1006.031082
  5. Ben-Zaken, O., S. Tzaban, Y. Tal, L. Horonchik, J. D. Esko, I. Vlodavsky, and A. Taraboulos. 2003. Cellular heparan sulfate participates in the metabolism of prions. J BioI. Chem. 278: 40041-40049 https://doi.org/10.1074/jbc.M301152200
  6. Bragason, B. T. and A. Palsdottir. 2005. Interaction of PrP with NRAGE, a protein involved in neuronal apoptosis. Mol. Cell. Neurosci. 29: 232-244 https://doi.org/10.1016/j.mcn.2005.02.013
  7. Brandner, S., S. Isenmann, A. Raeber, M. Fischer, A. Sailer, Y. Kobayashi, S. Marino, C. Weissmann, and A. Aguzzi. 1996. Normal host prion protein necessary for scrapieinduced neurotoxicity. Nature 379: 339-343 https://doi.org/10.1038/379339a0
  8. Brown, L. R. and D. A. Harris. 2002. The prion protein and copper: What is the connection?, pp. 103-113. In E. J. Massaro (ed.), Handbook of Copper Pharmacology and Toxicology. Humana Press, Totowa, NJ
  9. Brown, P. and R. Bradley. 1998. 1755 and all that: A historical primer of transmissible spongiform encephalopathy. Br. Med. J. 317: 1688-1692
  10. Bueler, H., M. Fisher, Y. Lang, H. Bluethmann, H.-P. Lipp, S. J. DeArmond, S. B. Prusiner, M. Aguet, and C. Weissmann. 1992. Normal development and behavior of mice lacking the neuronal cell-surface PrP protein. Nature 356: 577-582 https://doi.org/10.1038/356577a0
  11. Cashman, N. R., R. Loertscher, J. Nalbantoglu, I. Shaw, R. J. Kascsak, D. C. Bolton, and P. E. Bendheim. 1990. Cellular isoform of the scrapie agent protein participates in lymphocyte activation. Cell 61: 185-192 https://doi.org/10.1016/0092-8674(90)90225-4
  12. Castilla, J., P. Saa, C. Hetz, and C. Soto. 2005. In vitro generation of infectious scrapie prions. Cell 121 : 195-206 https://doi.org/10.1016/j.cell.2005.02.011
  13. Caughey, B., K. Brown, G. J. Raymond, G. E. Katzenstein, and W. Thresher. 1994. Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and Congo red. J. Virol. 68: 2135-2141
  14. Caughey, B. and P. T. Lansbury Jr. 2003. Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26: 267-298 https://doi.org/10.1146/annurev.neuro.26.010302.081142
  15. Caughey, B. and G. J. Raymond. 1991. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J. Biol. Chem. 266: 18217-18223
  16. Caughey, B. W., A. Dong, K. S. Bhat, D. Ernst, S. F. Hayes, and W. S. Caughey. 1991. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 30: 7672-7680 https://doi.org/10.1021/bi00245a003
  17. Chesebro, B., R. Race, K. Wehrly, J. Nishio, M. Bloom, D. Lechner, S. Bergstrom, K. Robbins, L. Mayer, J. M. Keith, C. Garon, and A. Haase. 1985. Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature 315: 331-333 https://doi.org/10.1038/315331a0
  18. Chiarini, L. B., A. R. Freitas, S. M. Zanata, R. R. Brentani, V. R. Martins, and R. Linden. 2002. Cellular prion protein transduces neuroprotective signals. EMBO J. 21: 3317-3326 https://doi.org/10.1093/emboj/cdf324
  19. Cohen, F. E., K.-M. Pan, Z. Huang, M. Baldwin, R. J. Fletterick, and S. B. Prusiner. 1994. Structural clues to prion replication. Science 264: 530-531 https://doi.org/10.1126/science.7909169
  20. Creutzfeldt, H. G. 1920. Uber eine eigenartige herdformige Erkrankung des Zentralnervensystems. Z. Gesamte Neurol. Psychiatrie 57: 1-18 https://doi.org/10.1007/BF02866081
  21. Cuccioloni, M., M. Amici, A. M. Eleuteri, M. Biagetti, S. Barocci, and M. Angeletti. 2005. Binding of recombinant $PrP^{c}$ to human plasminogen: Kinetic and thermodynamic study using a resonant mirror biosensor. Proteins 58: 728-734
  22. DeArmond, S. J., J. W Ironside, E. Bouzamondo-Bernstein, D. Peretz, and J. R. Fraser. 2004. Neuropathology of prion diseases, pp. 777-856. In S. B. Prusiner (ed.), Prion Biology and Diseases, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  23. DeArmond, S. J., M. P. McKinley, R. A. Barry, M. B. Braunfeld, J. R. McColloch, and S. B. Prusiner. 1985. Identification of prion amyloid filaments in scrapie-infected brain. Cell 41: 221-235 https://doi.org/10.1016/0092-8674(85)90076-5
  24. Deleault, N. R., J. C. Geoghegan, K. Nishina, R. Kascsak, R. A. Williamson, and S. Supattapone. 2005. Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. J. Biol. Chem. 280: 26873-26879 https://doi.org/10.1074/jbc.M503973200
  25. Edenhofer, F., R. Rieger, M. Famulok, W. Wendler, S. Weiss, and E.-L. Winnacker. 1996. Prion protein $PrP^{c}$ interacts with molecular chaperones of the Hsp60 family. J. Virol. 70: 4724-4728
  26. Ellis, V., M. Daniels, R. Misra, and D. R. Brown. 2002. Plasminogen activation is stimulated by prion protein and regulated in a copper-dependent manner. Biochemistry 41: 6891-6896 https://doi.org/10.1021/bi025676g
  27. Epple, G., K. Langfeld, M. Baier, H.-G. Holzhutter, W.-D. Schleuning, E. Kottgen, R. Gessner, and M. Praus. 2004. Both lysine-clusters of the $NH_{2}$-terminal prion-protein fragment PrP23-110 are essential for t-PA mediated plasminogen activation. Thromb. Haemost. 91: 465-472
  28. Epple, G., W.-D. Schleuning, G. Kettelgerdes, E. Kottgen, R. Gessner, and M. Praus. 2004. Prion protein stimulates tissuetype plasminogen activator-mediated plasmin generation via a lysine-binding site on kringle 2. J. Thromb. Haemost. 2: 962-968 https://doi.org/10.1111/j.1538-7836.2004.00675.x
  29. Fischer, M., T. Rulicke, A. Raeber, A. Sailer, M. Moser, B. Oesch, S. Brandner, A. Aguzzi, and C. Weissmann. 1996. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15: 1255-1264
  30. Fischer, M. B., C. Roeckl, P. Parizek, H. P. Schwarz, and A. Aguzzi. 2000. Binding of disease-associated prion protein to plasminogen. Nature 408: 479-483 https://doi.org/10.1038/35044100
  31. Fraser, H. and A. G. Dickinson. 1970. Pathogenesis of scrapie in the mouse: The role of the spleen. Nature 226: 462-463 https://doi.org/10.1038/226462a0
  32. Gabizon, R., Z. Meiner, M. Halimi, and S. A. Ben-Sasson. 1993. Heparin-like molecules bind differentially to prionproteins and change their intracellular metabolic fate. J. Cell. Physiol. 157: 319-325 https://doi.org/10.1002/jcp.1041570215
  33. Gambetti, P., Q. Kong, W. Zou, P. Parchi, and S. G. Chen. 2003. Sporadic and familial CJD: Classification and characterisation. Br. Med. Bull. 66: 213-239 https://doi.org/10.1093/bmb/66.1.213
  34. Gauczynski, S., D. Nikles, S. EI-Gogo, D. Papy-Garcia, C. Rey, S. Alban, D. Barritault, C. I. Lasmezas, and S. Weiss. 2006. The 37-kDa/67-kDa laminin receptor acts as a receptor for infectious prions and is inhibited by polysulfated glycanes. J. Inf. Dis. 194: 702-709 https://doi.org/10.1086/505914
  35. Gauczynski, S., J. M. Peyrin, S. Haik, C. Leucht, C. Hundt, R. Rieger, S. Krasemann, J. P. Deslys, D. Dormont, C. I. Lasmezas, and S. Weiss. 2001. The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J. 20: 5863-5875 https://doi.org/10.1093/emboj/20.21.5863
  36. Gibbs, C. J. Jr., D. C. Gajdusek, and R. Latarjet. 1978. Unusual resistance to ionizing radiation of the viruses of kuru, Creutzfeldt-Jakob disease. Proc. Natl. Acad. Sci. USA 75: 6268-6270
  37. Govaerts, C., H. Wille, S. B. Prusiner, and F. E. Cohen. 2004. Evidence for assembly of prions with left-handed ${\beta}$-helices into trimers. Proc. Natl. Acad. Sci. USA 101: 8342-8347
  38. Graner, E., A. F. Mercadante, S. M. Zanata, O. V. Forlenza, A. L. B. Cabral, S. S. Veiga, M. A. Juliano, R. Roesler, R. Walz, A. Mineti, I. Izquierdo, V. R. Martins, and R. R. Brentani. 2000. Cellular prion protein binds laminin and mediates neuritogenesis. Mol. Brain Res. 76: 85-92 https://doi.org/10.1016/S0169-328X(99)00334-4
  39. Harris, D. A., P. J. Peters, A. Taraboulos, V. Lingappa, S. J. DeArmond, and S. B. Prusiner. 2004. Cell biology of prions, pp. 483-544. In S. B. Prusiner (ed.), Prion Biology and Diseases, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  40. Hetz, C., M. Russelakis-Cameiro, K. Maundrell, J. Castilla, and C. Soto. 2003. Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J. 22: 5435-5445 https://doi.org/10.1093/emboj/cdg537
  41. Horonchik, L., S. Tzaban, O. Ben-Zaken, Y. Yedidia, A. Rouvinski, D. Papy-Garcia, D. Barritault, I. Vlodavsky, and A. Taraboulos. 2005. Heparan sulfate is a cellular receptor for purified infectious prions. J. Biol. Chem. 280: 17062-17067 https://doi.org/10.1074/jbc.M500122200
  42. Hundt, C., J. M. Peyrin, S. Haik, S. Gauczynski, C. Leucht, R. Rieger, M. L. Riley, J. P. Deslys, D. Dormont, C. I. Lasmezas, and S. Weiss. 2001. Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor. EMBO J. 20: 5876-5886 https://doi.org/10.1093/emboj/20.21.5876
  43. Jakob, A. 1921. Uber eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswertem anatomischen Befunde (spastische Pseudosklerose-Encephalomyelopathie mit disseminierten Degenerationsherden). Z. Gesamte Neurol. Psychiatrie 64: 147-228 https://doi.org/10.1007/BF02870932
  44. James, T. L., H. Liu, N. B. Ulyanov, S. Farr-Jones, H. Zhang, D. G. Donne, K. Kaneko, D. Groth, I. Mehlhorn, S. B. Prusiner, and F. E. Cohen. 1997. Solution structure of a 142residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc. Natl. Acad. Sci. USA 94: 10086-10091
  45. Jarrett, J. T. and P. T. Lansbury Jr. 1993. Seeding 'one-dimensional crystallization' of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73: 1055-1058 https://doi.org/10.1016/0092-8674(93)90635-4
  46. Kaneko, K., L. Zulianello, M. Scott, C. M. Cooper, A. C. Wallace, T. L. James, F. E. Cohen, and S. B. Prusiner. 1997. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc. Natl. Acad. Sci. USA 94: 10069-10074
  47. Keshet, G I., O. Bar-Peled, D. Yaffe, U. Nudel, and R. Gabizon. 2000. The cellular prion protein colocalizes with the dystroglycan complex in the brain. J. Neurochem. 75: 1889-1897 https://doi.org/10.1046/j.1471-4159.2000.0751889.x
  48. Kimberlin, R. H., S. Cole, and C. A. Walker. 1987. Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters. J. Gen. Virol. 68: 1875-1881 https://doi.org/10.1099/0022-1317-68-7-1875
  49. Kimberlin, R. H. and C. A. Walker. 1979. Pathogenesis of mouse scrapie: Dynamics of agent replication in spleen, spinal cord and brain after infection by different routes. J. Comp. Pathol. 89: 551-562 https://doi.org/10.1016/0021-9975(79)90046-X
  50. Klatzo, I., D. C. Gajdusek, and V. Zigas. 1959. Pathology of kuru. Lab. Invest. 8: 799-847
  51. Komblatt, J. A., S. Marchal, H. Razaei, and C. Balny. 2004. Characterization of a complex formed between human plasminogen and recombinant sheep prion: Pressure and thermal sensitivity of complex formation. Cell. Mol. Biol. (Noisy-Ie-grand) 50: 387-396
  52. Kornblatt, J. A., S. Marchal, H. Rezaei, M. J. Komblatt, C. Balny, R. Lange, M.-P. Debey, G. Hui Bon Hoa, M. C. Marden, and J. Grosclaude. 2003. The fate of the prion protein in the prion/plasminogen complex. Biochem. Biophys. Res. Commun. 305: 518-522 https://doi.org/10.1016/S0006-291X(03)00804-0
  53. Kurschner, C. and J. I. Morgan. 1995. The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast twohybrid system. Mol. Brain Res. 30: 165-168 https://doi.org/10.1016/0169-328X(95)00013-I
  54. Kuwahara, C., A. M. Takeuchi, T. Nishimura, K. Haraguchi, A. Kubosaki, Y. Matsumoto, K. Saeki, Y. Matsumoto, T. Yokoyama, S. Itohara, and T. Onodera. 1999. Prions prevent neuronal cell-line death. Nature 400: 225-226 https://doi.org/10.1038/22241
  55. Legname, G., I. V. Baskakov, H.-O. B. Nguyen, D. Riesner, F. E. Cohen, S. J. DeArmond, and S. B. Prusiner. 2004. Synthetic mammalian prions. Science 305: 673-676 https://doi.org/10.1126/science.1100195
  56. Leucht, C., S. Simoneau, C. Rey, K. Vana, R. Rieger, C. I. Lasmezas, and S. Weiss. 2003. The 37 kDa/67 kDa laminin receptor is required for $PrP^{Sc}$ propagation in scrapie-infected neuronal cells. EMBO Rep. 4: 290-295 https://doi.org/10.1038/sj.embor.embor768
  57. Leucht, C., K. Vana, I. Renner-Muller, D. Dormont, C. J. Lasmezas, E. Wolf, and S. Weiss. 2004. Knock-down of the 37-kDa/67-kDa laminin receptor in mouse brain by transgenic expression of specific antisense LRP RNA. Transgenic Res. 13: 81-85 https://doi.org/10.1023/B:TRAG.0000017177.35197.89
  58. Llewelyn, C. A., P. E. Hewitt, R. S. Knight, K. Amar, S. Cousens, J. Mackenzie, and R. G. Will. 2004. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363: 417-421 https://doi.org/10.1016/S0140-6736(04)15486-X
  59. Lucassen, R., K. Nishina, and S. Supattapone. 2003. In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups. Biochemistry 42: 4127-4135 https://doi.org/10.1021/bi027218d
  60. Maglio, L. E., M. F. Perez, V. R. Martins, R. R. Brentani, and O. A. Ramirez. 2004. Hippocampal synaptic plasticity in mice devoid of cellular prion protein. Mol. Brain Res. 131: 58-64 https://doi.org/10.1016/j.molbrainres.2004.08.004
  61. Maissen, M., C. Roeckl, M. Glatzel, W. Goldmann, and A. Aguzzi. 2001. Plasminogen binds to disease-associated prion protein of multiple species. Lancet 357: 2026-2028 https://doi.org/10.1016/S0140-6736(00)05110-2
  62. Manson, J. C., A. R. Clarke, M. L. Hooper, L. Aitchison, J. McConnell, and J. Hope. 1994. 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol. Neurobiol. 8: 121-127 https://doi.org/10.1007/BF02780662
  63. Marella, M., C. Gaggioli, M. Batoz, M. Deckert, S. TartareDeckert, and J. Chabry. 2005. Pathological prion protein exposure switches on neuronal mitogen-activated protein kinase pathway resulting in microglia recruitment. J. Biol. Chem. 280: 1529-1534 https://doi.org/10.1074/jbc.M410966200
  64. Martins, V. R., E. Graner, J. Garcia-Abreu, S. J. de Souza, A. F. Mercadante, S. S. Veiga, S. M. Zanata, V. M. Neto, and R. R. Brentani. 1997. Complementary hydropathy identifies a cellular prion protein receptor. Nat. Med. 3: 1376-1382 https://doi.org/10.1038/nm1297-1376
  65. McKinley, M. P., R. K. Meyer, L. Kenaga, F. Rahbar, R. Cotter, A. Serban, and S. B. Prusiner. 1991. Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J. Virol. 65: 1340-1351
  66. Moore, R. C., I. Y. Lee, G. L. Silverman, P. M. Harrison, R. Strome, C. Heinrich, A. Karunaratne, S. H. Pasternak, M. A. Chishti, Y. Liang, P. Mastrangelo, K. Wang, A. F. A. Smit, S. Katamine, G. A. Carlson, F. E. Cohen, S. B. Prusiner, D. W. Melton, P. Tremblay, L. E. Hood, and D. Westaway. 1999. Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J. Mol. Biol. 292: 797 -817 https://doi.org/10.1006/jmbi.1999.3108
  67. Mouillet-Richard, S., M. Ermonval, C. Chebassier, J. .-L. Laplanche, S. Lehmann, J. M. Launay, and O. Kellermann. 2000. Signal transduction through prion protein. Science 289: 1925-1928 https://doi.org/10.1126/science.289.5486.1925
  68. Nieznanski, K., H. Nieznanska, K. J. Skowronek, K. M. Osiecka, and D. Stepkowski. 2005. Direct interaction between prion protein and tubulin. Biochem. Biophys. Res. Commun. 334: 403-411 https://doi.org/10.1016/j.bbrc.2005.06.092
  69. Oesch, B., D. B. Teplow, N. Stahl, D. Serban, L. E. Hood, and S. B. Prusiner. 1990. Identification of cellular proteins binding to the scrapie prion protein. Biochemistry 29: 5848-5855 https://doi.org/10.1021/bi00476a029
  70. Oesch, B., D. Westaway, M. Walchli, M. P. McKinley, S. B. H. Kent, R. Aebersold, R. A. Barry, P. Tempst, D. B. Teplow, L. E. Hood, S. B. Prusiner, and C. Weissmann. 1985. A cellular gene encodes scrapie PrP 27-30 protein. Cell 40: 735- 746 https://doi.org/10.1016/0092-8674(85)90333-2
  71. Pan, K.-M., M. Baldwin, J. Nguyen, M. Gasset, A. Serban, D. Groth, I. Mehlhorn, Z. Huang, R. J. Fletterick, F. E. Cohen, and S. B. Prusiner. 1993. Conversion of ${\alpha}$-helices into ${\beta}$-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 90: 10962-10966
  72. Peden, A. H., M. W. Head, D. L. Ritchie, J. E. Bell, and J. W Ironside. 2004. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364: 527-529 https://doi.org/10.1016/S0140-6736(04)16811-6
  73. Petrakis, S. and T. Sklaviadis. 2006. Identification of proteins with high affinity for refolded and native $PrP^c$. Proteomics 6: 6476-6484 https://doi.org/10.1002/pmic.200600103
  74. Praus, M., G. Kettelgerdes, M. Baier, H.-G. Holzhtitter, P. R. Jungblut, M. Maissen, G. Epple, W.-D. Schleuning, E. Kottgen, A. Aguzzi, and R. Gessner. 2003. Stimulation of plasminogen activation by recombinant cellular prion protein is conserved in the NH2-terminal fragment PrP23-110. Thromb. Haemost. 89: 812-819 https://doi.org/10.1055/s-0037-1613466
  75. Prusiner, S. B. 1991. Molecular biology of prion diseases. Science 252: 1515-1522 https://doi.org/10.1126/science.1675487
  76. Prusiner, S. B. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216: 136-144 https://doi.org/10.1126/science.6801762
  77. Prusiner, S. B. 1998. Prions. Proc. Natl. Acad. Sci. USA 95: 13363-13383
  78. Prusiner, S. B. 2001. Shattuck Lecture: Neurodegenerative diseases and prions. N. Engl. J. Med. 344: 1516-1526 https://doi.org/10.1056/NEJM200105173442006
  79. Prusiner, S. B., M. Scott, D. Foster, K.-M. Pan, D. Groth, C. Mirenda, M. Torchia, S.-L. Yang, D. Serban, G. A. Carlson, P. C. Hoppe, D. Westaway, and S. J. DeArmond. 1990. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63: 673-686 https://doi.org/10.1016/0092-8674(90)90134-Z
  80. Race, R., M. Oldstone, and B. Chesebro. 2000. Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: Role of prion protein expression in peripheral nerves and spleen. J. Virol. 74: 828-833 https://doi.org/10.1128/JVI.74.2.828-833.2000
  81. Race, R. E., L. H. Fadness, and B. Chesebro. 1987. Characterization of scrapie infection in mouse neuroblastoma cells. J. Gen. Virol. 68: 1391-1399 https://doi.org/10.1099/0022-1317-68-5-1391
  82. Rieger, R., F. Edenhofer, C. I. Lasmezas, and S. Weiss. 1997. The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nat. Med. 3: 1383-1388 https://doi.org/10.1038/nm1297-1383
  83. Riek, R., S. Homemann, G. Wider, M. BiIleter, R. Glockshuber, and K. Wuthrich. 1996. NMR structure of the mouse prion protein domain PrP(121-231). Nature 382: 180-182 https://doi.org/10.1038/382180a0
  84. Rogers, M., F. Yehiely, M. Scott, and S. B. Prusiner. 1993. Conversion of truncated and elongated prion proteins into the scrapie isoform in cultured cells. Proc. Natl. Acad. Sci. USA 90: 3182-386
  85. Rossi, D., A. Cozzio, E. Flechsig, M. A. Klein, T. Rulicke, A. Aguzzi, and C. Weissmann. 2001. Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain. EMBO J. 20: 694-702 https://doi.org/10.1093/emboj/20.4.694
  86. Ryou, C., S. B. Prusiner, and G. Legname. 2003. Cooperative binding of dominant-negative prion protein to kringle domains. J. Mol. Biol. 329: 323-333 https://doi.org/10.1016/S0022-2836(03)00342-5
  87. Saborio, G. P., B. Permanne, and C. Soto. 2001. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411: 810-813 https://doi.org/10.1038/35081095
  88. Sakaguchi, S., S. Katamine, N. Nishida, R. Moriuchi, K. Shigematsu, T. Sugimoto, A. Nakatani, Y. Kataoka, T. Houtani, S. Shirabe, H. Okada, S. Hasegawa, T. Miyamoto, and T. Noda. 1996. Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 380: 528-531 https://doi.org/10.1038/380528a0
  89. Salmona, M., R. Capobianco, L. Colombo, A. De Luigi, G. Rossi, M. Mangieri, G. Giaccone, E. Quaglio, R. Chiesa, M. B. Donati, F. Tagliavini, and G. Forloni. 2005. Role of plasminogen in propagation of scrapie. J. Virol. 79: 11225-11230 https://doi.org/10.1128/JVI.79.17.11225-11230.2005
  90. Santuccione, A., V. Sytnyk, I. Leshchyns'ka, and M. Schachner. 2005. Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J. Cell Sci. 169: 341-354 https://doi.org/10.1083/jcb.200409127
  91. Schmitt-Dims, G., G. Legname, M. A. Baldwin, H. L. Ball, N. Bradon, P. J. Bosque, K. L. Crossin, G. M. Edelman, S. J. DeArmond, F. E. Cohen, and S. B. Prusiner. 2001. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J. Mol. Biol. 314: 1209-1225 https://doi.org/10.1006/jmbi.2000.5183
  92. Scott, M., D. Foster, C. Mirenda, D. Serban, F. Coufal, M. Walchli, M. Torchia, D. Groth, G. Carlson, S. J. DeArmond, D. Westaway, and S. B. Prusiner. 1989. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cells 9: 847-857
  93. Scott, M., D. Peretz, R. M. Ridley, H. F. Baker, S. J. DeArmond, and S. B. Prusiner. 2004. Transgenetic investigations of the species barrier and prion strains, pp. 435-482. In S. B. Prusiner (ed.), Prion Biology and Diseases, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  94. Shaked, G. M., Z. Meiner, I. Avraham, A. Taraboulos, and R. Gabizon. 2001. Reconstitution of prion infectivity from solubilized protease-resistant PrP and nonprotein components ofprion rods. J. Biol. Chem. 276: 14324-14328 https://doi.org/10.1074/jbc.M007815200
  95. Shaked, Y., R. Engelstein, and R. Gabizon. 2002. The binding of prion proteins to serum components is affected by detergent extraction conditions. J. Neuroehem. 82: 1-5 https://doi.org/10.1046/j.1471-4159.2002.00995.x
  96. Sohn, H. J., J. H. Kim, K. S. Choi, J. J. Nah, Y. S. Joo, Y. H. Jean, S. W. Ahn, O. K. Kim, D. Y. Kim, and A. Balachandran. 2002. A case of chronic wasting disease in an elk imported to Korea from Canada. J. Vet. Med. Sci. 64: 855-858 https://doi.org/10.1292/jvms.64.855
  97. Spielhaupter, C. and H. M. Schatzl. 2001. $PrP^{c}$ directly interacts with proteins involved in signaling pathways. J. Biol. Chem. 276: 44604-44612 https://doi.org/10.1074/jbc.M103289200
  98. Stahl, N., D. R. Borchelt, K. Hsiao, and S. B. Prusiner. 1987. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cells 1: 229-240
  99. Steele, A. D., J. G. Emsley, P. H. Ozdinler, S. Lindquist, and J. D. Macklis. 2006. Prion protein ($PrP^c$) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis. Proc. Natl. Acad. Sci. USA 103: 3416-3421
  100. Telling, G. C., M. Scott, J. Mastrianni, R. Gabizon, M. Torchia, F. E. Cohen, S. J. DeArmond, and S. B. Prusiner. 1995. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83: 79-90 https://doi.org/10.1016/0092-8674(95)90236-8
  101. Vana, K. and S. Weiss. 2006. A trans-dominant negative V37 kDa/67 kDa laminin receptor mutant impairs $PrP^{Sc}$ propagation in scrapie-infected neuronal cells. J. Mol. Biol. 358: 57-66 https://doi.org/10.1016/j.jmb.2006.02.011
  102. Warner, R. G, C. Hundt, S. Weiss, and J. E. Turnbull. 2002. Identification of the heparan sulfate binding sites in the cellular prion protein. J. Biol. Chem. 277: 18421-18430 https://doi.org/10.1074/jbc.M110406200
  103. Wells, G A. H., A. C. Scott, C. T. Johnson, R. F. Gunning, R. D. Hancock, M. Jeffrey, M. Dawson, and R. Bradley. 1987. A novel progressive spongiform encephalopathy in cattle. Vet. Rec. 121: 419-420 https://doi.org/10.1136/vr.121.18.419
  104. Wells, G A. H. and J. W. Wilesmith. 2004. Bovine spongiform encephalopathy and related diseases, pp. 595-628. In S. B. Prusiner (ed.), Prion Biology and Diseases, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  105. Will, R. G, M. P. Alpers, D. Dormont, and L. B. Schonberger. 2004. Infectious and sporadic prion diseases, pp. 629-671. In S. B. Prusiner (ed.), Prion Biology and Diseases, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  106. Will, R. G, J. W. Ironside, M. Zeidler, S. N. Cousens, K. Estibeiro, A. Alperovitch, S. Poser, M. Pocchiari, A. Hofman, and P. G Smith. 1996. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347: 921-925 https://doi.org/10.1016/S0140-6736(96)91412-9
  107. Williams, E. S. 2005. Chronic wasting disease. Vet. Pathol. 42: 530-549 https://doi.org/10.1354/vp.42-5-530
  108. Wong, C. N., L.-W. Xiong, M. Horiuchi, L. Raymond, K. Wehrly, B. Chesebro, and B. Caughey. 2001. Sulfated glycans and elevated temperature stimulate $PrP^{Sc}$ -dependent cell-free formation of protease-resistant prion protein. EMBO J. 20: 377-386 https://doi.org/10.1093/emboj/20.3.377
  109. Xanthopoulos, K., I. Paspaltsis, V. Apostolidou, S. Petrakis, C. J. Siao, A. Kalpatsanidis, N. Grigoriadis, A. Tsaftaris, S. E. Tsirka, and T. Sklaviadis. 2005. Tissue plasminogen activator in brain tissues infected with transmissible spongiform encephalopathies. Neurobiol. Dis. 20: 519-527 https://doi.org/10.1016/j.nbd.2005.04.008
  110. Yehiely, F., P. Bamborough, M. D. Costa, B. J. Perry, G. Thinakaran, F. E. Cohen, G. A. Carlson, and S. B. Prusiner. 1997. Identification of candidate proteins binding to prion protein. Neurobiol. Dis. 3: 339-355 https://doi.org/10.1006/nbdi.1997.0130
  111. Zanata, S. M., M. H. Lopes, A. F. Mercadante, G. N. Hajj, L. B. Chiarini, R. Nomizo, A. R. Freitas, A. L. Cabral, K. S. Lee, M. A. Juliano, E. de Oliveira, S. G. Jachieri, A. Burlingame, L. Huang, R. Linden, R. R. Brentani, and V. R. Martins. 2002. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J. 21: 3307-3316 https://doi.org/10.1093/emboj/cdf325
  112. Zerr, I., M. Bodemer, U. Kaboth, H. Kretzschmar, M. Oellerich, and V. W. Armstrong. 2004. Plasminogen activities and concentrations in patients with sporadic CreutzfeldtJakob disease. Neurosci. Lett. 371: 163-166 https://doi.org/10.1016/j.neulet.2004.08.063
  113. Zhang, C. C., A. D. Steele, S. Lindquist, and H. F. Lodish. 2006. Prion protein is expressed on long-term repopulating hematopoietic stem cells and is important for their selfrenewal. Proc. Natl. Acad. Sci. USA 103: 2184-2189
  114. Zulianello, L., K. Kaneko, M. Scott, S. Erpel, D. Han, F. E. Cohen, and S. B. Prusiner. 2000. Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein. J. Virol. 74: 4351-4360 https://doi.org/10.1128/JVI.74.9.4351-4360.2000